1,2-bis[3,5-bis(4-Methoxybenzylidene)-4-oxo-piperidin-1-yl]ethane-1,2-dione

ID: ALA2391208

PubChem CID: 71699611

Max Phase: Preclinical

Molecular Formula: C44H40N2O8

Molecular Weight: 724.81

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(/C=C2\CN(C(=O)C(=O)N3C/C(=C\c4ccc(OC)cc4)C(=O)/C(=C/c4ccc(OC)cc4)C3)C/C(=C\c3ccc(OC)cc3)C2=O)cc1

Standard InChI:  InChI=1S/C44H40N2O8/c1-51-37-13-5-29(6-14-37)21-33-25-45(26-34(41(33)47)22-30-7-15-38(52-2)16-8-30)43(49)44(50)46-27-35(23-31-9-17-39(53-3)18-10-31)42(48)36(28-46)24-32-11-19-40(54-4)20-12-32/h5-24H,25-28H2,1-4H3/b33-21+,34-22+,35-23+,36-24+

Standard InChI Key:  DQPWMXAGEGCSJD-KZFAHMCXSA-N

Molfile:  

     RDKit          2D

 54 59  0  0  0  0  0  0  0  0999 V2000
   14.5655  -10.8406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2681  -11.2580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8521  -11.2416    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2689  -12.0696    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5647  -12.4842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5724  -13.3026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2843  -13.7063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9885  -13.2916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9807  -12.4733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2920  -14.5246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.6989  -13.6922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3997  -13.2764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3892  -12.4580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0919  -12.0386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8051  -12.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8156  -13.2558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1129  -13.6753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8682  -13.7173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1557  -13.3060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1552  -12.4888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4459  -12.0806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7411  -12.4896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7416  -13.3068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4468  -13.7150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5743  -10.0259    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2878   -9.6249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2987   -8.8066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5961   -8.3892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8827   -8.7902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8718   -9.6085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6070   -7.5709    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1801   -8.3728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4666   -8.7737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7641   -8.3563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0527   -8.7537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0418   -9.5720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7444   -9.9894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4579   -9.5885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0121   -8.4057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7186   -8.7991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7321   -9.6174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4469  -10.0160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1481   -9.5963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1345   -8.7781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4198   -8.3795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9782  -10.8535    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3289   -9.9715    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6265   -9.5538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0329  -12.0820    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.0317  -11.2648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8623   -9.9935    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.5633   -9.5735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5074  -12.0196    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.2204  -12.4188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  4  9  1  0
  7 10  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
  8 11  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 19 24  2  0
  6 18  2  0
  2  4  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 25 30  1  0
 28 31  2  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 33 38  2  0
 29 32  2  0
 39 40  1  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 45  1  0
 40 45  2  0
 27 39  2  0
  1 25  1  0
  2 46  2  0
 36 47  1  0
 47 48  1  0
 22 49  1  0
 49 50  1  0
 43 51  1  0
 51 52  1  0
 15 53  1  0
 53 54  1  0
M  END

Associated Targets(Human)

HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Raji (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ramos (1218 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJAB (157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
YT (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC70 (557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LAPC4 (305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HS27 (243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EL4 (235 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 724.81Molecular Weight (Monoisotopic): 724.2785AlogP: 6.18#Rotatable Bonds: 8
Polar Surface Area: 111.68Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 6.57CX LogD: 6.57
Aromatic Rings: 4Heavy Atoms: 54QED Weighted: 0.16Np Likeness Score: -0.16

References

1. Das S, Das U, Michel D, Gorecki DK, Dimmock JR..  (2013)  Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells.,  64  [PMID:23644215] [10.1016/j.ejmech.2013.03.055]
2. Santiago-Vazquez Y, Das S, Das U, Robles-Escajeda E, Ortega NM, Lema C, Varela-Ramírez A, Aguilera RJ, Balzarini J, De Clercq E, Dimmock SG, Gorecki DK, Dimmock JR..  (2014)  Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicity.,  77  [PMID:24657568] [10.1016/j.ejmech.2014.03.009]

Source